| Literature DB >> 26903787 |
Abstract
Today it is well acknowledged that both nature and nurture play important roles in the genesis of psychopathologies, including drug addiction. Increasing evidence suggests that genetic factors contribute for at least 40-60% of the variation in liability to drug dependence. Human genetic studies suggest that multiple genes of small effect, rather than single genes, contribute to the genesis of behavioral psychopathologies. Therefore, the use of inbred rat strains might provide a valuable tool to identify differences, linked to genotype, important in liability to addiction and related disorders. In this regard, Lewis and Fischer 344 inbred rats have been proposed as a model of genetic vulnerability to drug addiction, given their innate differences in sensitivity to the reinforcing and rewarding effects of drugs of abuse, as well their different responsiveness to stressful stimuli. This review will provide evidence in support of this model for the study of the genetic influence on addiction vulnerability, with particular emphasis on differences in mesolimbic dopamine (DA) transmission, rewarding and emotional function. It will be highlighted that Lewis and Fischer 344 rats differ not only in several indices of DA transmission and adaptive changes following repeated drug exposure, but also in hypothalamic-pituitary-adrenal (HPA) axis responsiveness, influencing not only the ability of the individual to cope with stressful events, but also interfering with rewarding and motivational processes, given the influence of corticosteroids on dopamine neuron functionality. Further differences between the two strains, as impulsivity or anxiousness, might contribute to their different proneness to addiction, and likely these features might be linked to their different DA neurotransmission plasticity. Although differences in other neurotransmitter systems might deserve further investigation, results from the reviewed studies might open new vistas in understanding aberrant deviations in reward and motivational functions.Entities:
Keywords: Fischer 344 rats; HPA axis; Lewis rats; addiction; impulsivity; reward
Year: 2016 PMID: 26903787 PMCID: PMC4746315 DOI: 10.3389/fnins.2016.00013
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Results of drug self-administration studies in LEW and F344 rats.
| FR1, 3, 4, 8, 16, 1 h | LEW > F344 | LEW > F344 | – | – | – | – | George, |
| FR1, 2, 4, 8, 1 h | LEW > F344 | LEW > F344 | – | – | – | – | Suzuki et al., |
| FR1, 23 h; | LEW > F344 | LEW > F344 | – | LEW > F344 | Ambrosio et al., | ||
| FR1, PR, 12 h; | LEW > F344 | LEW > F344 | LEW > F344 | LEW = F344 | Martín et al., | ||
| F344 > LEW | Ambrosio et al., | ||||||
| FR1, 3, 5, 1 h; | LEW > F344 | LEW > F344 | LEW > F344 | LEW > F344 (with cues) | LEW > F344 | Di Chiara et al., | |
| PR, 4 h; | LEW = F344 (without cues) | ||||||
| FR1, 18 h | LEW > F344 | LEW > F344 | LEW Yes F344 No | Picetti et al., | |||
| FR1, 2 h | Neither acquired | – | – | – | – | – | Shoaib et al., |
| FR1, 23 h | LEW > F344 | LEW > F344 | Brower et al., | ||||
| FR1, 2 h | LEW > F344 | LEW > F344 | – | – | – | – | Kosten et al., |
| F344 > LEW | F344 > LEW | – | – | – | Kosten et al., | ||
| LEW = F344 | LEW = F344 | LEW = F344 | LEW > F344 | Miguéns et al., | |||
| LEW = F344 | LEW = F344 | – | F344 > LEW | LEW > F344 | Kruzich and Xi, | ||
| FR1, 6 h; PR | LEW > F344 | F344 > LEW | LEW = F344 | – | Freeman et al., | ||
| FR1, 18 h | LEW = F344 | LEW Yes | – | Picetti et al., | |||
| FR1-FR5, 1 h | LEW > F344 LEW > F344 | LEW > F344 LEW > F344 | – | – | LEW = F344 | LEW = F344 | Meyer et al., |
| FR1, 2 h | – | LEW > F344 | – | – | F344 > LEW | LEW > F344 | Kruzich and Xi, |
For each drug operant schedule (FR, fixed Ratio; PR, Progressive Ratio) and length of session is reported. - data not available.
Differences between LEW and F344 strains in HPA axis activity in different conditions.
| Basal conditions | LEW=F344 | LEW=F344 | LEW=F344 | LEW=F344 | – | LEW=F344 | – | – | Sternberg et al., |
| – | |||||||||
| LEW=F344 | Ergang et al., | ||||||||
| LEW < F344 | LEW>F344 | Ergang et al., | |||||||
| LEW>F344 | LEW<F344 | LEW<F344 | Dhabhar et al., | ||||||
| LEW<F344 | – | Smith et al., | |||||||
| Circadian variation | ♀ LEW Yes | Griffin and Whitacre, | |||||||
| ♀ F344 No | |||||||||
| ♀ LEW No | |||||||||
| ♁ F344 Yes | |||||||||
| Stress | LEW<F344 | LEW<F344 | LEW<F344 | – | – | – | Sternberg et al., | ||
| LEW=F344 | Rivest and Rivier, | ||||||||
| LEW>F344 | Moncek et al., | ||||||||
| ↓LEW=F344 | LEW<F344 | Dhabhar et al., | |||||||
| LEW>F344 | ↑F344 | Ergang et al., | |||||||
| Prolonged stress exposure | – | LEW < F344 | LEW < F344 | – | – | – | – | – | Dhabhar et al., |
| Chronic stress | ↑ LEW=F344 | LEW > F344 | LEW < F344 LEW < F344 | ↓ LEW=F344 (hippocampus) | – | ↓ LEW=F344 (hippocampus) | – | – | Gómez et al., |
| Nicotine | – | – | LEW < F344 | – | – | – | – | – | Grota et al., |
| Morphine | – | – | LEW < F344 | – | – | – | – | – | Baumann et al., |
| Cocaine | LEW < F344 | LEW > F344 | LEW < F344 | – | – | – | – | – | Simar et al., |
Data of CORT and ACTH refer to serum levels, CRF refers to mRNA expression in paraventricular nucleus (PVN) of the hypothalamus (except for data following cocaine administration) as well as GR and MR data refer to mRNA levels in the areas indicated. Abbreviations: CRF corticotrophin releasing factor, ACTH adrenocorticotropic hormone, CORT corticosterone, GRs glucocorticoid receptors, MRs mineralocorticoid receptors, 11HSD1 11β-hydroxysteroid dehydrogenase type 1, CBG corticosteroid-binding globulin. Symbols used: ↑ up-regulation; ↓ down-regulation; ↔ no change; - data not available.